2017
Prognostic value of NK and T-lymphocytes markers in operable non-small cell lung cancer (NSCLC).
Skrzypski M, Szymanowska-Narloch A, Jassem E, Marczyk M, Polanska J, Biernat W, Rzyman W, Maciejewska A, Pawlowski R, Jassem J. Prognostic value of NK and T-lymphocytes markers in operable non-small cell lung cancer (NSCLC). Journal Of Clinical Oncology 2017, 35: 11556-11556. DOI: 10.1200/jco.2017.35.15_suppl.11556.Peer-Reviewed Original ResearchNon-small cell lung cancerRelapsed non-small cell lung cancerDistant metastasis-free survivalNormal lung parenchymaPrognostic valueLung parenchymaOperable non-small cell lung cancerEarly-stage non-small cell lung cancerShorter distant metastasis-free survivalStage non-small cell lung cancerNK activation markersNSCLC histological typesExpression of CXCR3Immune-targeted therapiesEndothelin receptor type BIIIA NSCLC patientsMetastasis-free survivalNK cell markersCell lung cancerT lymphocyte markersNormal lung tissuesPrimary resectionFree survivalNK cellsNSCLC patients
2016
Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer
Bobowicz M, Skrzypski M, Czapiewski P, Marczyk M, Maciejewska A, Jankowski M, Szulgo-Paczkowska A, Zegarski W, Pawłowski R, Polańska J, Biernat W, Jaśkiewicz J, Jassem J. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer. Clinical & Experimental Metastasis 2016, 33: 765-773. PMID: 27485175, PMCID: PMC5110606, DOI: 10.1007/s10585-016-9810-1.Peer-Reviewed Original ResearchConceptsDistant metastasis-free survivalColon cancerMMR statusShorter distant metastasis-free survivalEarly-stage colon cancerMiR-592 expressionGroup of patientsMetastasis-free survivalExpression signaturesCox univariate analysisStage colon cancerNormal colon mucosa samplesColon mucosa samplesMiRNA expression signaturesAdjuvant chemotherapyDistant relapseMiRNA expressionDistant metastasisMiR-423-5pCC patientsPrognostic significancePrognostic valueSuch therapyUnivariate analysisHigh risk